Posted On: June 4, 2008 by David Payne

Trasylol Litigation Plaintiffs’ Steering Committee: The Missouri Law Firm Of Carey & Danis, LLC Appointed

Having friends in high places is good. And for Missouri Trayslol clients, the news is good. The home-state team has the St. Louis law firm of Carey & Danis sitting in on the Plaintiffs' Steering Committee.

John J. Carey of Carey & Danis has been appointed to serve as a member of the plaintiffs’ steering committee in the multidistrict Trasylol litigation pending before a Florida federal court. “Our firm is honored to fill this important role on behalf of Trasylol victims and their families. Having served as lead counsel or steering committee members in several pharmaceutical cases, we understand that swift justice requires efficient case management,” commented Carey of the appointment.

U.S. District Court Judge Donald M. Middlebrooks entered the order announcing the plaintiffs’ steering committee, which is responsible for managing and conducting the pretrial proceedings, in the cases of Trasylol products liability litigation.

Judge Middlebrooks has a reputation for being conscientious and hard-working and as early as next summer hopes to be trying Trasylol cases. The venue is also known for having fair juries.

The U.S. Food and Drug Administration approved Trasylol way back in 1993.
But since 2006, three studies have linked the clotting drug to an increased risk of stroke, heart attack and kidney failure. Then on May 14, the New England Journal of Medicine published the BART study, which revealed that patients given Trasylol had a death rate 53 percent higher than that of heart-surgery patients given cheaper competing drugs.

These facts reveal the worse of irresponsible and dangerous corporate greed!!

Danis' firm currently has 13 cases involving Bayer’s anti-bleeding drug Trasylol (aprotinin) pending in the multidistrict litigation. Trasylol12.jpg

The complaints filed with the courts claim that Bayer failed to warn prescribers and consumers of the dangers associated with the drug, defectively designed the drug, fraudulently concealed the dangers of the drug, breached the implied and express warranties and violated various state laws.

The plaintiffs are seeking compensatory damages and damages for aggravating circumstances.

The firm anticipates filing an additional 50 cases in the near future involving heart-surgery patients who suffered kidney failure after receiving Trasylol.

Call a Missouri Trayslol attorney for more information.